Cleared Traditional

K201833 - BiPad Hand Activated

K201833 is an FDA 510(k) clearance for BiPad Hand Activated, manufactured by Bipad Surgical, Inc.. The device is a Class 2 General & Plastic Surgery device with product code GEI cleared through the Traditional 510(k) pathway after a 29-day FDA review.

K201833 · Bipad Surgical, Inc. · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2020
Decision
29d
Days
Class 2
Risk

K201833 is an FDA 510(k) clearance for the BiPad Hand Activated, Disposable Bipolar Electrocautery Cords. Classified as Electrosurgical, Cutting & Coagulation & Accessories within the GEI classification (a category for electrosurgical cutting and coagulation devices), Class II - Special Controls.

Submitted by Bipad Surgical, Inc. (Point Lookout, US). The FDA issued a Cleared decision on July 31, 2020 after a review of 29 days - a notably fast clearance cycle.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4400 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Bipad Surgical, Inc. devices

FDA 510(k) Submission Details - K201833

510(k) Number K201833 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 02, 2020
Decision Date July 31, 2020
Days to Decision 29 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
86d faster than avg
Panel avg: 115d · This submission: 29d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

GEI Device Classification - Class 2, Special Controls

Product Code GEI Electrosurgical, Cutting & Coagulation & Accessories
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.4400
Definition Validated Reprocessing Instructions And Reprocessing Validation Data For This Device Type Must Be Included In A 510(k) Submission If The Device Is Reusable And Has Specific Design Features (please Refer To Table 2 Of 82 Fr 26807, Available At Https://www.gpo.gov/fdsys/pkg/fr-2017-06-09/pdf/2017-12007.pdf).
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Consultant

Accelerated Device Approval Services
Rafael Aguila

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - GEI Electrosurgical, Cutting & Coagulation & Accessories

All 1257
Devices cleared under the same product code (GEI) and FDA review panel - the closest regulatory comparables to K201833.
BTL-785F
K193201 · Btl · Aug 2020
Aurora Evacuator +Coag
K201637 · Rebound Therapeutics · Aug 2020
Electrodes Handpieces for Mygen V-1000 RF System
K193355 · RF Medical Co., Ltd. · Aug 2020
Single Use Electrosurgical Knife
K193601 · Micro-Tech (Nanjing) Co., Ltd. · Jul 2020
InMode RF Multi-System
K201150 · Inmode , Ltd. · Jul 2020
Encision AEM enTouch 2X Scissor
K201018 · Encision, Inc. · Jul 2020

FDA 510(k) Resources - General & Plastic Surgery

Additional regulatory intelligence related to this FDA 510(k) submission, including predicate strategy, review pathways and device classification guidance.